CD274 and intrahepatic cholangiocarcinoma: On the other hand, PD-L1 positivity on tumor-infiltrating immune cells, which may reflect a pre-existing anti-tumor immune response, has been associated with better prognosis of other cancer sites, including intrahepatic cholangiocarcinoma [57], and head and neck [58] cancers.